Defects in ATM could also be compensated through the activity of ataxia telangiectasia And rad3-related protein (ATR), thus indicating potential synthetic lethality interactions between these pathways, as ATM mutated tumours would be vulnerable to ATR inhibition [52]. The gene discussed is ATM; the disease is neoplasm.